These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 23756255

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
    Wei Q, Shui Y, Zheng S, Wester K, Nordgren H, Nygren P, Glimelius B, Carlsson J.
    Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
    [Abstract] [Full Text] [Related]

  • 3. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
    Siegfried JM, Lin Y, Diergaarde B, Lin HM, Dacic S, Pennathur A, Weissfeld JL, Romkes M, Nukui T, Stabile LP.
    Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
    [Abstract] [Full Text] [Related]

  • 4. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J.
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [Abstract] [Full Text] [Related]

  • 5. Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
    Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P.
    Breast; 2014 Oct; 23(5):637-43. PubMed ID: 25017122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells.
    Hirata A, Hosoi F, Miyagawa M, Ueda S, Naito S, Fujii T, Kuwano M, Ono M.
    Cancer Res; 2005 May 15; 65(10):4253-60. PubMed ID: 15899817
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
    Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes RM, Busund LT.
    J Thorac Oncol; 2010 Oct 15; 5(10):1536-43. PubMed ID: 20802349
    [Abstract] [Full Text] [Related]

  • 11. Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.
    Cappuzzo F, Gregorc V, Rossi E, Cancellieri A, Magrini E, Paties CT, Ceresoli G, Lombardo L, Bartolini S, Calandri C, de Rosa M, Villa E, Crino L.
    J Clin Oncol; 2003 Jul 15; 21(14):2658-63. PubMed ID: 12860941
    [Abstract] [Full Text] [Related]

  • 12. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.
    Wei Q, Chen L, Sheng L, Nordgren H, Wester K, Carlsson J.
    Int J Oncol; 2007 Sep 15; 31(3):493-9. PubMed ID: 17671674
    [Abstract] [Full Text] [Related]

  • 13. Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.
    Tomasich E, Steindl A, Paiato C, Hatziioannou T, Kleinberger M, Berchtold L, Puhr R, Hainfellner JA, Müllauer L, Widhalm G, Eckert F, Bartsch R, Heller G, Preusser M, Berghoff AS.
    Clin Cancer Res; 2023 Aug 15; 29(16):3225-3236. PubMed ID: 37036472
    [Abstract] [Full Text] [Related]

  • 14. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H, Hanssen A, Loges S, Mohme M, Bernreuther C, Peine S, Lamszus K, Goy Y, Petersen C, Westphal M, Glatzel M, Riethdorf S, Pantel K, Wikman H.
    Sci Rep; 2019 May 15; 9(1):7406. PubMed ID: 31092882
    [Abstract] [Full Text] [Related]

  • 15. Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.
    Ekberg T, Nestor M, Engström M, Nordgren H, Wester K, Carlsson J, Anniko M.
    Int J Oncol; 2005 May 15; 26(5):1177-85. PubMed ID: 15809707
    [Abstract] [Full Text] [Related]

  • 16. Investigation of HER2 overexpression in non-small cell lung cancer.
    Ugocsai K, Mándoky L, Tiszlavicz L, Molnár J.
    Anticancer Res; 2005 May 15; 25(4):3061-6. PubMed ID: 16080566
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
    Baek MY, Ahn HK, Park KR, Park HS, Kang SM, Park I, Kim YS, Hong J, Sym SJ, Park J, Lee JH, Shin DB, Cho EK.
    Korean J Intern Med; 2018 Jan 15; 33(1):168-175. PubMed ID: 27093978
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer.
    Hirsch FR, Varella-Garcia M, Cappuzzo F.
    Oncogene; 2009 Aug 15; 28 Suppl 1():S32-7. PubMed ID: 19680294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.